Company Data

Raphael Pharmaceutical Inc Com (New)

Current Price
Market Cap
Price Target
Refer to Report
52wk Range
$0.6 - $1.67
Advanced Market Data


Raphael Pharmaceutical Inc., a pharmaceutical drug research and development company, focuses on the discovery and clinical development of life-improving drug therapies based on cannabidiol and oil. It develops product candidate for the treatment of rheumatoid arthritis, oncology indications, and hyper inflammatory syndrome inflammation related to COVID-19. Raphael Pharmaceutical Inc. is headquartered in Tel Aviv-Yafo, Israel.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy